Correlation Between Apogee Therapeutics, and Compania Cervecerias

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Compania Cervecerias at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Compania Cervecerias into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Compania Cervecerias Unidas, you can compare the effects of market volatilities on Apogee Therapeutics, and Compania Cervecerias and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Compania Cervecerias. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Compania Cervecerias.

Diversification Opportunities for Apogee Therapeutics, and Compania Cervecerias

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Apogee and Compania is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Compania Cervecerias Unidas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compania Cervecerias and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Compania Cervecerias. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compania Cervecerias has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Compania Cervecerias go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Compania Cervecerias

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 4.49 times more return on investment than Compania Cervecerias. However, Apogee Therapeutics, is 4.49 times more volatile than Compania Cervecerias Unidas. It trades about 0.11 of its potential returns per unit of risk. Compania Cervecerias Unidas is currently generating about 0.25 per unit of risk. If you would invest  4,385  in Apogee Therapeutics, Common on September 24, 2024 and sell it today you would earn a total of  386.00  from holding Apogee Therapeutics, Common or generate 8.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  Compania Cervecerias Unidas

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Compania Cervecerias 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Compania Cervecerias Unidas are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating fundamental indicators, Compania Cervecerias may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Apogee Therapeutics, and Compania Cervecerias Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and Compania Cervecerias

The main advantage of trading using opposite Apogee Therapeutics, and Compania Cervecerias positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Compania Cervecerias can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compania Cervecerias will offset losses from the drop in Compania Cervecerias' long position.
The idea behind Apogee Therapeutics, Common and Compania Cervecerias Unidas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Valuation
Check real value of public entities based on technical and fundamental data